Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters.Semin Perinatol. 2005; 29: 252-257
- Estimation of gestational age by transvaginal sonographic measurements of greatest embryonic length in dated human embryos.Ultrasound Obstet Gynecol. 1994; 4: 457-462
- Abdominal ultrasound examination of the first trimester fetus.Am J Obstet Gynecol. 1988; 159: 165-175
- First trimester transvaginal sonographic diagnosis of fetal anomalies.Lancet. 1989; 1: 444-445
- The role of transvaginal sonography in the early detection of congenital heart disease.Ultrasound Obstet Gynecol. 1992; 2: 248-251
- Assessment of fetal anatomy at 12 to 13 weeks of gestation by transabdominal and transvaginal sonography.Br J Obstet Gynaecol. 1996; 103: 82-85
- Screening for fetal anomalies in the 12th week of pregnancy by transvaginal sonography in an unselected population.Prenat Diagn. 1997; 17: 753-759
- First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population.Br J Obstet Gynaecol. 1998; 105: 53-57
- Detection of fetal structural abnormalities at the 11-14 week ultrasound scan.Prenat Diagn. 2002; 22: 1-4
- Screening for major structural abnormalities at the 11- to 14-week ultrasound scan.Am J Obstet Gynecol. 2006; 194: 393-396
- Early diagnosis of fetal congenital heart disease by transvaginal echocardiography.Ultrasound Obstet Gynecol. 1993; 3: 310-317
- First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography.Obstet Gynecol. 1994; 84: 69-72
- The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy.Arch Gynecol Obstet. 2003; 268: 94-101
- Detailed screening for fetal anomalies and cardiac defects at the 11-13 week scan.Ultrasound Obstet Gynecol. 2006; 27: 613-618
- Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation.Ultrasound Obstet Gynecol. 1996; 7: 245-250
- Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.Br J Obstet Gynaecol. 1999; 106: 1029-1034
- Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.Am J Obstet Gynecol. 2005; 192: 1357-1361
- Nuchal translucency: a marker for the antenatal diagnosis of aortic coarctation.Br J Obstet Gynaecol. 1996; 103: 1044-1045
- Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.Ultrasound Obstet Gynecol. 1997; 10: 242-246
- Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.Br J Obstet Gynaecol. 1999; 106: 829-833
- Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype.Ultrasound Obstet Gynecol. 2001; 18: 610-614
- Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency.Ultrasound Obstet Gynecol. 2003; 22: 470-478
- Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation.J Matern Fetal Neonatal Med. 2003; 13: 163-170
- Fetal cardiac defects and increased nuchal translucency thickness [abstract 571].Am J Obstet Gynecol. 2003; 189
- Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.Br Med J. 1999; 318: 81-85
- Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects.Ultrasound Obstet Gynecol. 2001; 17: 106-110
- Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience.Eur J Obstet Gynecol Reprod Biol. 2002; 101: 124-128
- Increased nuchal translucency and congenital heart defects in a low-risk population.Prenat Diagn. 2003; 23: 985-989
- Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.Am J Obstet Gynecol. 2003; 189: 1330-1335
- Omphalocele-exstrophy-imperforate anus-spinal defects (OEIS) complex associated with increased nuchal translucency.Ultrasound Obstet Gynecol. 2003; 22: 95-97
- Fetal nuchal translucency thickness at 10-14 weeks of gestation and congenital diaphragmatic hernia.Obstet Gynecol. 1997; 90: 943-947
- Prenatal ultrasound diagnosis and management of body stalk anomaly: analysis of nine singleton and two multiple pregnancies.Ultrasound Obstet Gynecol. 2003; 21: 322-328
- Sirenomelia sequence: first-trimester diagnosis with both two- and three-dimensional sonography.J Ultrasound Med. 2002; 21: 915-920
- Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation.Ultrasound Obstet Gynecol. 1998; 11: 391-400
- Increased nuchal translucency with normal karyotype.in: Sebire N.J. Snijders R.J.M. Nicolaides K.H. The 11-14 week scan: diagnosis of fetal abnormalities. Parthenon Publishing, Carnforth (UK)1999: 67-88
- Increased nuchal translucency with normal karyotype.Am J Obstet Gynecol. 2005; 192: 1005-1021
- Increased nuchal translucency is associated with asphyxiating thoracic dysplasia.Ultrasound Obstet Gynecol. 1997; 10: 297-298
- Achondrogenesis type 2 diagnosed by transvaginal ultrasound at 12 weeks of gestation.Prenat Diagn. 1993; 13: 523-528
- Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester.Am J Med Genet. 2001; 98: 117-120
- Transvaginal ultrasound recognition of nuchal oedema in the first-trimester diagnosis of achondrogenesis.J Clin Ultrasound. 1991; 19: 586-590
- Achondrogenesis type I diagnosed by transvaginal ultrasonography at 13 weeks' gestation.Am J Obstet Gynecol. 1995; 173: 1620-1622
- First trimester diagnosis of Blomstrand lethal osteochondrodysplasia.Am J Med Genet. 1997; 73: 345-350
- Hypophosphatasia associated with increased nuchal translucency: a report of three consecutive pregnancies.Ultrasound Obstet Gynecol. 2002; 20: 294-295
- Early sonographic diagnosis of Jarcho-Levin syndrome: a prospective screening program in one family.Ultrasound Obstet Gynecol. 1997; 9: 314-318
- Upper limb phocomelia associated with increased nuchal translucency in a monochorionic twin pregnancy.J Ultrasound Med. 2002; 21: 355-360
- Prenatal diagnosis of pseudothalidomide syndrome in consecutive pregnancies of a consanguineous couple.Ultrasound Obstet Gynecol. 1997; 10: 425-428
- First-trimester diagnosis of Robinow syndrome.Fetal Diagn Ther. 2001; 16: 308-311
- Transvaginal sonographic diagnosis of short-rib polydactyly dysplasia at 13 weeks' gestation.Prenat Diagn. 1998; 18: 1198-1201
- Noonan syndrome: a cryptic condition in early gestation.Am J Med Genet. 2000; 92: 159-165
- Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation.Prenat Diagn. 2002; 22: 91-92
- Increased first-trimester nuchal translucency as a prenatal manifestation of salt-wasting congenital adrenal hyperplasia.Ultrasound Obstet Gynecol. 2002; 20: 392-394
- Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester.Prenat Diagn. 2002; 22: 93-95
- Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation.Ultrasound Obstet Gynecol. 1997; 9: 310-313
- Sonographic and maternal serum screening abnormalities in fetuses affected by spinal muscular atrophy.Prenat Diagn. 1997; 17: 166-169
- The association of spinal muscular atrophy type II and increased nuchal translucency.Ultrasound Obstet Gynecol. 2002; 19: 312-313
- Nuchal translucency in fetuses affected by homozygous a-thalassemia-1 at 12-13 weeks of gestation.Ultrasound Obstet Gynecol. 1999; 13: 238-240
- Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation.Ultrasound Obstet Gynecol. 2002; 20: 197-199
- Congenital erythropoietic porphyria (Gunther's disease): two cases with very early prenatal manifestation and cystic hydroma.Prenat Diagn. 2003; 23: 25-30
- Fanconi anemia associated with increased nuchal translucency detected by first-trimester ultrasound.Ultrasound Obstet Gynecol. 2001; 17: 160-162
- Fetal hydrops secondary to human parvovirus infection in early pregnancy.Prenat Diagn. 1996; 16: 342-344
- Parvoviral infection associated with increased nuchal translucency: a case report.J Perinatol. 2000; 20: 129-131
- Fetal hydrops in the first trimester associated with maternal parvovirus infection.J Clin Ultrasound. 1998; 26: 314-316
- First-trimester diagnosis of nuchal anomalies: significance and fetal outcome.Ultrasound Obstet Gynecol. 1992; 2: 314-316
- Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.J Med Genet. 1998; 35: 222-224
- Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester.Ultrasound Obstet Gynecol. 2001; 18: 9-17
- Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency.Fetal Diagn Ther. 2001; 16: 360-363
- Outcome of fetuses with enlarged nuchal translucency and normal karyotype.Ultrasound Obstet Gynecol. 1998; 11: 401-406
- Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.Ultrasound Obstet Gynecol. 2001; 17: 102-105
- Clinical course and outcome of fetuses with isolated cystic nuchal lesions and normal karyotypes detected in the first trimester.Am J Obstet Gynecol. 1994; 171: 1278-1281
- Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening.Int J Gynaecol Obstet. 2004; 84: 5-9
- Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype.Prenat Diagn. 2002; 22: 345-349
- Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype.Prenat Diagn. 1996; 16: 537-541
- Early and simple determination of chorionic and amniotic type in multifetal gestations in the first 14 weeks by high frequency transvaginal ultrasound.Am J Obstet Gynecol. 1994; 170: 824-829
- The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies.Ultrasound Obstet Gynecol. 1996; 7: 421-423
- Evolution of the lambda or twin/chorionic peak sign in dichorionic twin pregnancies.Obstet Gynecol. 1997; 89: 439-441
- Maternal serum free beta-hCG at 10 to 14 weeks in trisomic twin pregnancies.BJOG. 1997; 104: 741-743
- Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness.Prenat Diagn. 2000; 20: 91-95
- Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.BJOG. 2003; 110: 276-280
- Ductus venosus Doppler at 11 to 13 weeks of gestation in the prediction of outcome in twin pregnancies.Obstet Gynecol. 2009; 113: 860-865
- Assessment of fetal anatomy at the 11-14 week ultrasound examination.Ultrasound Obstet Gynecol. 2004; 24: 730-734
- First-trimester sonography of physiological midgut herniation and early diagnosis of omphalocele.Prenat Diagn. 1997; 17: 511-518
- Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation.Ultrasound Obstet Gynecol. 1995; 6: 250-255
- Ultrasound screening for anencephaly at 10-14 weeks of gestation.Ultrasound Obstet Gynecol. 1997; 9: 14-16
- A mixture model of nuchal translucency thickness in screening for chromosomal defects.Ultrasound Obstet Gynecol. 2008; 31: 376-383
- The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester.Ultrasound Obstet Gynecol. 1998; 11: 258-261
- Optimising the timing for nuchal translucency measurement.Prenat Diagn. 2002; 22: 775-777
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.Lancet. 1998; 351: 343-346
- Absence of nasal bone in fetuses with Trisomy 21 at 11-14 weeks of gestation: an observational study.Lancet. 2001; 358: 1665-1667
- Fronto-maxillary facial angle in fetuses with Trisomy 21 at 11-13 (+6) weeks'.Am J Obstet Gynecol. 2007; 196: 271
- Screening for trisomy 21 by tricuspid regurgitation, nuchal translucency and maternal serum free β-hCG and PAPP-A at 11 +0 to 13 +6 weeks.Ultrasound Obstet Gynecol. 2006; 27: 151-155
- The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation.Ultrasound Obstet Gynecol. 2001; 17: 295-300
- Fetal heart rate in chromosomally abnormal fetuses.Ultrasound Obstet Gynecol. 2000; 16: 610-613
- Single Umbilical Artery at 11-14 weeks: relation to chromosomal defects.Ultrasound Obstet Gynecol. 2003; 22: 567-570
- Fetal megacystis at 10-14 weeks of gestation.Ultrasound Obstet Gynecol. 1996; 8: 387-390
- Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length.Ultrasound Obstet Gynecol. 2003; 21: 338-341
- Early fetal megacystis between 11 and 15 weeks of gestation.Ultrasound Obstet Gynecol. 1999; 14: 402-406
- Ultrasonographically detectable markers of fetal chromosomal abnormalities.Lancet. 1992; 340: 704-707
- Observations on an ethnic classification of idiots.Clin Lectures and Reports, London Hospital. 1866; 3: 259-262
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.Br Med J. 1992; 304: 867-889
- Nuchal translucency measurements: frequency, distribution, and changes with gestation in a general population.Br J Obstet Gynaecol. 1996; 103: 1201-1204
- The effect of fetal neck position on nuchal translucency measurement at 10-14 weeks.Br J Obstet Gynaecol. 1998; 105: 872-876
- The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks.Ultrasound Obstet Gynecol. 1998; 11: 271-273
- Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation.Obstet Gynecol. 2006; 107: 678-683
- Correlation between nuchal thickness and abnormal karyotype in first trimester fetuses.Med J Aust. 1996; 165: 365-368
- Nuchal translucency and congenital heart defects: heart failure or not?.Ultrasound Obstet Gynecol. 2000; 16: 30-36
- Abnormal cardiac function in fetuses with increased nuchal translucency.Ultrasound Obstet Gynecol. 2003; 21: 539-542
- Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses.Obstet Gynecol. 1996; 87: 506-510
- Atrial natriuretic peptide distribution in fetal and failed adult human hearts.Circulation. 1988; 78: 920-927
- Increased cardiac muscle size and reduced cell number in Down syndrome.Pediatr Pathol. 1986; 6: 47-53
- Morphological classification of nuchal skin in fetuses with trisomy 21, 18 and 13 at 12-18 weeks and in a trisomy 16 mouse.Anat Embryol. 1998; 197: 105-124
- Collagen type VI gene expression in the skin of trisomy 21 fetuses.Obstet Gynecol. 1998; 91: 319-323
- Hyaluronan in the nuchal skin of chromosomally abnormal fetuses.Hum Reprod. 2000; 15: 1155-1158
- Collagen type VI expression during cardiac development and in human fetuses with trisomy 21.Anat Rec. 2003; 275A: 1109-1116
- Collagen XVIII/endostatin is associated with the epithelial-mesenchymal transformation in the atrioventricular valves during cardiac development.Dev Dyn. 2006; 235: 132-142
- Lymphatic abnormalities in fetuses with posterior cervical cystic hygroma.Am J Med Genet. 1989; 33: 352-356
- Lymphatic vessel hypoplasia in fetuses with Turner syndrome.Hum Reprod. 1999; 14: 823
- Fetoscopy in the assessment of unexplained fetal hydrops.Br J Obstet Gynaecol. 1985; 92: 671-679
- Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester.Fetal Diagn Ther. 2000; 15: 234-236
- Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.Ultrasound Obstet Gynecol. 1998; 12: 163-169
- A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol. 1999; 13: 231-237
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry and in a one-stop clinic: a review of three years prospective experience.BJOG. 2003; 110: 281-286
- Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol. 2008; 31: 618-624
- Prospective validation of first-trimester combined screening for trisomy 21.Ultrasound Obstet Gynecol. 2009; 34: 14-18
- Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.Ultrasound Obstet Gynecol. 2005; 25: 221-226
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.Am J Obstet Gynecol. 2005; 192: 1761-1767
- Screening for trisomies 21,18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate free beta-hCG and pregnancy-associated plasma protein-A.Hum Reprod. 2008; 23: 1968-1975
- Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11-13 weeks and 6 days of gestation.Prenat Diagn. 2008; 28: 1209-1213
- Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.Ultrasound Obstet Gynecol. 2008; 4: 488-492
- Association between first trimester absence of fetal nasal bone on ultrasound and Down's syndrome.Prenat Diagn. 2002; 22: 930-932
- Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.Prenat Diagn. 2003; 23: 496-500
- Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses.Prenat Diagn. 2003; 23: 784-787
- Nasal bone hypoplasia: is it a common finding amongst chromosomally normal fetuses of southern Chinese women?.Gynecol Obstet Invest. 2003; 56: 99-101
- Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.Ultrasound Obstet Gynecol. 2003; 22: 31-35
- Nasal bone assessment in prenatal screening for trisomy 21.Am J Obstet Gynecol. 2006; 195: 1219-1230
- Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.J Matern Fetal Neonatal Med. 2002; 11: 400-402
- Assessment of the fetal nasal bone at 11-14 weeks of gestation by three-dimensional ultrasound.Ultrasound Obstet Gynecol. 2004; 23: 232-236
- Likelihood ratio for Trisomy 21 in fetuses with absent nasal bone at the 11-14 weeks scan.Ultrasound Obstet Gynecol. 2004; 23: 218-223
- Integrated ultrasound and biochemical screening for trisomy 21 using nuchal translucency, absent fetal nasal bone, free beta and PAPP A at 11 to 14 weeks.Prenat Diagn. 2003; 23: 306-310
- Nasal bone assessment in prenatal screening for trisomy 21.Am J Obstet Gynecol. 2006; 195 (2009): 109-144
- Fetal nasal bone in screening for trisomy 21, 18, 13 and Turner syndrome at 11-13 weeks of gestation.Ultrasound Obstet Gynecol. 2009; 33: 259-264
- Frontomaxillary facial angle at 11 +0 to 13 +6 weeks: effect of plane of acquisition.Ultrasound Obstet Gynecol. 2007; 29: 660-665
- Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks' gestation.Am J Obstet Gynecol. 2007; 197: 160
- Frontomaxillary facial angle in chromosomally normal fetuses at 11 +0 to 13 +6 weeks.Ultrasound Obstet Gynecol. 2007; 30: 737-741
- Frontomaxillary facial angle in screening for trisomy 21 at 11 +0 to 13 +6 weeks.Ultrasound Obstet Gynecol. 2008; 32: 5-11
- Frontomaxillary facial angle in fetuses with trisomy 13 at 11 +0 to 13 +6 weeks.Ultrasound Obstet Gynecol. 2007; 30: 819-823
- Frontomaxillary and mandibulomaxillary facial angles at 11 +0 to 13 +6 weeks in fetuses with trisomy 18.Ultrasound Obstet Gynecol. 2007; 30: 928-933
- Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus.Ultrasound Obstet Gynecol. 1994; 4: 109-114
- Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies.Circulation. 1995; 91: 129-138
- Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13 +6 weeks of gestation.Obstet Gynecol. 2008; 112: 598-605
- Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus.BJOG. 2002; 109: 1015-1019
- Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy.Fetal Diagn Ther. 2002; 1: 308-314
- First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype.Fetal Diagn Ther. 2002; 17: 52-57
- Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy.Prenat Diagn. 2003; 23: 921-926
- Ductus venosus Doppler in screening for trisomies 21, 18, and 13 and Turner syndrome at 11-13 weeks of gestation.Ultrasound Obstet Gynecol. 2009; 33: 512-517
- Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.Ultrasound Obstet Gynecol. 2001; 17: 288-294
- Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.Ultrasound Obstet Gynecol. 2008; 31: 256-260
- Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation.Heart. 2003; 89: 1071-1073
- Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 +6 week scan.Ultrasound Obstet Gynecol. 2005; 26: 22-27
- Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 +0 to 13 +6 weeks of gestation.Ultrasound Obstet Gynecol. 2009; 33: 18-22
- Nuchal translucency measurement: training of potential examiners.Ultrasound Obstet Gynecol. 1996; 8: 192-195
- Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks.Ultrasound Obstet Gynecol. 2003; 22: 135-137
- Learning curve for Doppler assessment of ductus venosus flow at 11-13 +6 weeks' gestation.Ultrasound Obstet Gynecol. 2008; 31: 503-506
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
